Showing results (81-90 of 148) with videos related to
Sort By:
Pageof 15
Clinical Pharmacology and Therapeutics|September 1, 1976
Relationship between the pharmacokinetics and pharmacodynamics of procainamideR L Galeazzi, L Z Benet, L B SheinerAmerican Journal of Public Health|April 1, 1989
Improving the homogeneity of diagnosis-related groups (DRGs) by using clinical laboratory, demographic, and discharge dataE S Goldman, M J Easterling, L B SheinerJournal of Pharmaceutical Sciences|May 18, 2001
A semiparametric deconvolution model to establish in vivo-in vitro correlation applied to OROS oxybutyninM Pitsiu, G Sathyan, S Gupta, et al.Journal of Pharmacokinetics and Biopharmaceutics|October 1, 1994
Comparison of the Akaike Information Criterion, the Schwarz criterion and the F test as guides to model selectionT M Ludden, S L Beal, L B SheinerMethods of Information in Medicine|August 1, 1991
Combining physiologic models and symbolic methods to interpret time-varying patient dataM G Kahn, L M Fagan, L B SheinerClinical Pharmacology and Therapeutics|January 1, 1992
A pharmacodynamic model of erythropoietin therapy for uremic anemiaD E Uehlinger, F A Gotch, L B SheinerJournal of Pharmacokinetics and Biopharmaceutics|April 1, 1981
Predicting individual phenytoin dosageS Vozeh, K T Muir, L B Sheiner, et al.Clinical Pharmacology and Therapeutics|November 1, 1993
Zidovudine response relationships in early human immunodeficiency virus infectionM Sale, L B Sheiner, P Volberding, et al.Clinical Pharmacology and Therapeutics|September 1, 1979
Forecasting individual pharmacokineticsL B Sheiner, S Beal, B Rosenberg, et al.Journal of Pharmacokinetics and Biopharmaceutics|June 1, 1996
Do we need full compliance data for population pharmacokinetic analysis?P Girard, L B Sheiner, H Kastrissios, et al.Pageof 15